Skip to main content
. Author manuscript; available in PMC: 2007 Jan 8.
Published in final edited form as: J Med Primatol. 2006 Jun;35(3):165–171. doi: 10.1111/j.1600-0684.2006.00152.x

Fig. 4.

Fig. 4

Effect of therapeutic immunization on cytotoxic T lymphocyte and NK activity. Target cells: Vγ 481 middle surface antigen; vp 541: 4BV core antigen; vp551: large surface antigen; K562 target for NK cells.